GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity) work through multiple mechanisms to control blood glucose and reduce appetite
Options include a breast lift (mastopexy) to restore position and shape, breast augmentation with a lift to restore both volume and position, or breast reduction for patients who desire a smaller, more proportionate size
BPC-157 is not an FDA-approved drug in any form, and no approved formulation exists
Long-term use should be monitored with regular health checks to track GH production, body composition, and hormone balance
The cost of the drugs and problems were insurance were a common reason for patients stopping GLP-1 treatment, along with side effects and medication shortages, researchers said